Division of Cardiology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Am J Cardiol. 2019 Nov 15;124(10):1561-1567. doi: 10.1016/j.amjcard.2019.08.008. Epub 2019 Aug 22.
Red cells distribution width (RDW) is a measure of red cell size variability, but little is known about the relation between RDW and outcomes in atrial fibrillation (AF).The aims of our study were to evaluate the association between RDW values, AF patients' profile and outcomes. Consecutive patients with ECG-confirmed AF were divided in 3 groups according to tertiles of RDW values (≤13.5%, 13.6% to 14.6%, >14.6%).We enrolled 457 patients, 61.9% males, median (interquartile range) age 74 (66 to 80). Both CHADS-VASc and HAS-BLED scores increased progressively according to RDW tertiles. During follow-up, there was an increased risk for all-cause death and the composite end point in the highest RDW tertile (p <0.001 for both outcomes). On multivariate Cox regression analysis, the highest RDW tertile was independently associated with all-cause death (hazard ratio [HR] 3.23, 95% confidence interval [CI] 1.04 to 10.00) and the composite end point (HR 2.04, 95% CI 1.12 to 3.70). RDW as a continuous variable was also independently associated with all cause death and the composite outcome (HR 1.16, 95% CI 1.02 to 1.31 and HR 1.16, 95% CI 1.05 to 1.27, respectively). In conclusion, in a real-life AF population, RDW is associated with clinical factors indicating a worse profile and is independently associated with increased risks of all-cause death and other clinical events.
红细胞分布宽度(RDW)是红细胞大小变异性的一种度量,但关于 RDW 与心房颤动(AF)患者结局之间的关系知之甚少。我们的研究目的是评估 RDW 值与 AF 患者特征和结局之间的关系。连续经心电图确诊为 AF 的患者根据 RDW 值的三分位数(≤13.5%、13.6%至 14.6%、>14.6%)分为 3 组。我们共纳入 457 名患者,男性占 61.9%,中位(四分位间距)年龄为 74 岁(66 至 80 岁)。CHADS-VASc 和 HAS-BLED 评分均随 RDW 三分位数的升高而逐渐增加。在随访期间,RDW 最高三分位数组全因死亡和复合终点的风险增加(两个结局的 P 值均<0.001)。多变量 Cox 回归分析显示,RDW 最高三分位数与全因死亡(危险比 [HR] 3.23,95%置信区间 [CI] 1.04 至 10.00)和复合终点(HR 2.04,95% CI 1.12 至 3.70)独立相关。RDW 作为连续变量也与全因死亡和复合结局独立相关(HR 1.16,95% CI 1.02 至 1.31 和 HR 1.16,95% CI 1.05 至 1.27)。总之,在真实的 AF 人群中,RDW 与提示预后较差的临床因素相关,与全因死亡和其他临床事件风险增加独立相关。